Abstract
The history of ADHD in the twenty-first century was summarized using 5 topics (diagnosis, epidemiology, treatment, prognosis, and pathophysiology). Brief reviews were provided for changes in the official criteria, stability of worldwide prevalence, increases in pharmacological treatment, persistence into adulthood, and biological bases of ADHD.
References
ADHD-200 Consortium (2012) The ADHD-200 Consortium: a model to advance the translational potential of neuroimaging in clinical neuroscience. Front Syst Neurosci 6:1–5
American Psychiatric Association (1968) DSM-II. American Psychiatric Association, Washington, DC
American Psychiatric Association (1980) DSM-III. American Psychiatric Association, Washington, DC
American Psychiatric Association (1994) DSM-IV. American Psychiatric Association, Washington, DC
American Psychiatric Association (2013) DSM-5. American Psychiatric Association, Washington, DC
Asherson P (2004) IMAGE consortium. ADHD in the post-genomic era. Eur Child Adolesc Psychiatry 13:150–170
Barkley RA (1997) Behavioral inhibition, sustained attention, and executive functions: constructing a unifying theory of ADHD. Psychol Bull 121:65–94
Barkley RA, Fischer M, Smallish L, Fletcher K (2002) The persistence of ADHD into young adulthood as a function of reporting source and definition of disorder. J Abnorm Psychol 111:279–289
Biswal BB, Mennes M, Zuo XN et al (2010) Toward discovery science of human brain function. Proc Natl Acad Sci U S A 107:4734–4739
Brookes K, Xu X, Chen W et al (2006) The analysis of 51 genes in DSM-IV combined type ADHD: association signals in DRD4, DAT1, and 16 other genes. Mol Psychiatry 11:934–953
Castellanos FX, Proal E (2012) Large-scale brain systems in ADHD: beyond the prefrontal-striatal model. Trends Cogn Sci 16:17–26
Cross-disorder Group of the Psychiatric Genomics Consortium (2013) Genetic relationship between five psychiatric disorders estimated from genome-wide SNPs. Nat Genet 45:984–994
Cuthbert BN, Insel TR (2013) Toward the future of psychiatric diagnosis: the seven pillars of RDoC. BMC Med 11:1–8
Dalsgaard S, Nielson HS, Simonsen M (2014) Consequences of ADHD medication use for children’s outcomes. J Health Econ 37:137–151
Faraone SV (2014) Advances in genetics of ADHD. Biol Psychiatry 76:599–600
Faraone SV, Biederman J, Mick E (2006) The age-dependent decline of ADHD: a meta-analysis of follow-up studies. Psychol Med 36:159–165
Faraone SV, Asherson P, Banaschewski T et al (2015) ADHD. Nat Rev 1:1–23
Franke B, Neale BM, Faraone SV (2009) GWAS in ADHD. Hum Genet 126:13–50
Grady DL, Chi HC, Ding YC et al (2003) High prevalence of rare dopamine receptor D4 alleles in children diagnosed with ADHD. Mol Psychiatry 8:536–545
Jensen PS, Arnold LE, Swanson JM et al (2007) 3-year follow-up of the NIMH MTA study. J Am Acad Child Adolesc Psychiatry 46:988–1001
Klein RG, Abikoff H, Hechtman L et al (2004) Design and rationale of controlled study of long-term methylphenidate and multimodal psychosocial treatment in children with ADHD. J Am Acad Child Adolesc Psychiatry 43:792–801
Lichtenstein P, Halldner L, Zetterqvist J et al (2012) Medication for ADHD and criminality. NEJM 367:2006–2014
Martin J, Hamshere ML, Stergiakouli E et al (2014) Genetic risk for ADHD contributes to neurodevelopmental traits in the general population. Biol Psychiatry 76:664–671
McCarthy S, Wilton L, Murray ML et al (2012) The epidemiology of pharmacological treated ADHD in children, adolescents, and adults in UK primary care. BMC Pediatr 12:1–11
Moffitt TE, Houts R, Asherson P et al (2015) Is adult ADHD a childhood-onset neurodevelopmental disorder? Evidence from a four-decade longitudinal cohort study. Am J Psychiatry 172:967–977
Molina SG, Hinshaw SP, Arnold LE et al (2013) Adolescent substance use in the MTA as a function of childhood ADHD. J Am Acad Child Adolesc Psychiatry 52:250–263
MTA Group (1999) A 14-month randomized clinical trial of treatment strategies for ADHD. Arch Gen Psychiatry 56:1073–1086
MTA Group (2004) NIMH MTA follow-up: changes in effectiveness and growth. Pediatrics 113:762–769
Neale BM, Midland SE, Ripke S et al (2010a) Meta-analysis of GWAS of ADHD. J Am Acad Child Adolesc Psychiatry 49:884–897
Neale BM, Medland S, Ripke S et al (2010b) Case–control GWAS of ADHD. J Am Acad Child Adolesc Psychiatry 49:906–920
Owens JS, Matthew E, Goldfine NM et al (2006) A critical review of self-perceptions and the positive illusionary bias in children with ADHD. Clin Child Fam Psychol Rev 10:335–351
Polanczyk GV, Willcutt EG, Salum GA et al (2014) ADHD prevalence estimates across three decades: an updated systematic review and meta-regression analysis. Int J Epidemiol 43:434–442
Psychiatric GWAS Consortium Steering Committee (2009) A framework for interpreting genome-wide association studies of psychiatric disorders. Mol Psychiatry 14:10–17
Safer D (2016) Recent trends in stimulant usage. J of Att Dis 20(6):471–477
Sibley M, Swanson JM, Arnold LE et al (2016) Defining ADHD symptom persistence in adulthood: optimizing sensitivity and specificity. Submitted
Sonuga-Barke EJS (2002) Psychological heterogeneity in ADHD: a dual pathway model of behavior and attention. Behav Brain Res 130:29–36
Sonuga-Barke EJS, Brandeis DF, Cortese S et al (2013) Non-pharmacological interventions for ADHD: systematic review and meta-analysis of randomized controlled trials of dietary and psychological treatments. Am J Psychiatry. 170(3):275–89. doi: 10.1176/appi.ajp.2012.12070991. Review
Still GF (1902) Some abnormal psychical conditions in children. Lancet 1:1008–1012, 1077–1082, 1163–1168
Swanson JM, Volkow ND (2008) Increasing use of stimulants warns of potential abuse. Nature 453:586
Swanson JM, Volkow ND (2009) Psychopharmacology: concepts and opinions about the use of stimulant medications. J Child Psychol Psychiatry 50:180–193
Swanson JM, Lerner MA, Williams L (1995) More frequent diagnosis of ADHD. N Engl J Med 333:944
Swanson JM, Sergeant J, Taylor E, Sonuga-Barke EJS, Jensen PS, Cantwell DP (1998) Attention-deficit hyperactivity disorder and hyperkinetic disorder. Lancet 351:429–433
Swanson JM, Arnold LE, Molina B et al (2016) Outcomes in the 16-year follow-up of the MTA: persistence of symptoms and medication side effects in early adulthood. Submitted
Tomasi D, Volkow ND (2012) Abnormal functional connectivity in children with ADHD. Biol Psychiatry 71:443–450
Tomasi D, Volkow ND (2014) Functional connectivity of substantia nigra and ventral tegmental area: maturation during adolescence and effects of ADHD cerebral cortex 24:935–944
Visser SN, Danielson ML, Bitsko RH et al (2014) Trends in the parent report of health care provider-diagnosed and medicated ADHD: US, 2003–2011. J Am Acad Child Adolesc Psychiatry 53:34–46
Volkow ND, Swanson JM (2013) Adult ADHD. N Engl J Med 369:1935–1944
Volkow NDF, Wang GJ, Kollins SH et al (2009) Evaluating dopamine reward pathways in ADHD. JAMA 302:1084–1091
Weiss G, Kruger E, Danielson U et al (1975) Effect of long-term treatment of hyperactive children with methylphenidate. CMA J 112:159–165
WHO (1966) The ICD-8 classification of mental and behavioral disorders. WHO, Geneva
WHO (1993) The ICD-10 classification of mental and behavioral disorders. WHO, Geneva
Willcutt EG, Doyle AE, Nigg JT et al (2005) Validity of the executive function theory of ADHD: a meat-analytic review. Biol Psychiatry 57:1336–1346
Williams NM, Franke B, Mick ER et al (2012) Genome-wide CNVs in ADHD confirms the roles of rare variants and implicates duplications at 15q13.3. Am J Psychiatry 169:195–204
Yeo BT, Krienen FM, Sepulcre J et al (2011) The organization of the human cerebral cortex estimated by intrinsic functional connectivity. J Neurophysiol 106:1125–1165
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2016 Springer Science+Business Media New York
About this entry
Cite this entry
Swanson, J.M., Sergeant, J.A., Taylor, E.A., Sonuga-Barke, E.J.S., Jensen, P.S., Castellanos, F.X. (2016). Attention Deficit Hyperactivity Disorder. In: Pfaff, D., Volkow, N. (eds) Neuroscience in the 21st Century. Springer, New York, NY. https://doi.org/10.1007/978-1-4614-6434-1_169-1
Download citation
DOI: https://doi.org/10.1007/978-1-4614-6434-1_169-1
Received:
Accepted:
Published:
Publisher Name: Springer, New York, NY
Online ISBN: 978-1-4614-6434-1
eBook Packages: Springer Reference Biomedicine and Life SciencesReference Module Biomedical and Life Sciences
Publish with us
Chapter history
-
Latest
Attention-Deficit Hyperactivity Disorder- Published:
- 07 September 2022
DOI: https://doi.org/10.1007/978-1-4614-6434-1_169-2
-
Original
Attention Deficit Hyperactivity Disorder- Published:
- 08 April 2016
DOI: https://doi.org/10.1007/978-1-4614-6434-1_169-1